Teva gets FDA approval for generic Prevacid
Teva Pharmaceutical receives FDA approval for generic version of heartburn drug Prevacid
- On 4:42 pm EST, Tuesday November 10, 2009
NEW YORK (AP) -- Teva Pharmaceutical Industries Ltd. said Tuesday the Food and Drug Administration approved its generic version of the heartburn drug Prevacid.
Teva will sell 15-milligram and 30-milligram delayed-release capsule versions of the drug.
Teva said the branded version of Prevacid had sales of about $2.97 billion in the 12 months ended June 30.
Shares of Israel-based Teva fell 43 cents to close at $52.77.
Related Headlines
- Turning to Widow and Orphan Stocks - at Barrons.com
- Momenta rises on upgrade ahead of Lovenox ruling - AP
- Moody's gives negative view on pharma credit - AP
- Harvard Endowment Favors Mix of ETFs, International Names - Indie Research
- 5-Star Manager's Global Stock Picks - at CNBC
Related Blog Headlines
- Cephalon Settles Barr Challenge - Zacks.com
- Santarus, Depomed Poised to Gain from Anticipated Sales of Glumetza - at Seeking Alpha
- What Pfizer, KKR and Goldman (Reportedly) Want: Generics! - at The Wall Street Journal Online
- Bionovo: Challenges Ahead, But Poised to Move Higher - at Seeking Alpha
- Cephalon's Upside and Downside - at Seeking Alpha
Sponsored Links
-
Trade Stocks? Try Currency Trading
Trade in a highly trending market 24-hrs a day, 5.5 days a week. GFT. -
Buy Stocks for $4
No account or investment minimums. No inactivity fees. Start Today.
-
Earn From 1.90% to 2.20% Apply Online
With GE Capital Corporation. Not An Offer Of Securities For Sale. -
Super Cheap Car Insurance Quotes
Get Discount Auto Insurance Quotes Online - Rates from $15 / Month.
Tech Ticker Recent Posts
- Are We Really Better Off Than We Were a Year Ago? - Peter Gorenstein
- Dollar Slumps After Fed Talks Turkey: Can Stocks Keep Up with Gold? - Aaron Task
- Don't Blame the Shorts: A History of Misplaced Aggression - Heesun Wee
Add Alert Copyright © 2009 The Associated Press. All rights reserved. The information contained in the AP News report may not be published, broadcast, rewritten, or redistributed without the prior written authority of The Associated Press.